Federal contract award

HHSN27200029

IGF::OT::IGF NIAID PRECLINICAL DEVELOPMENT SUPPORT - PRODUCTION OF ECD-IG PROTEIN

Research the contractorView USAspending sourceSave to my pursuit research

Award details

Obligations, current value and potential value describe different measures; they are never added together.

FieldReported value
AgencyDepartment of Health and Human Services
OfficeNATIONAL INSTITUTES OF HEALTH NIAID
NAICS541712
PSCAN81 — AIDS RESEARCH - BASIC RESEARCH
Parent award / vehicleHHSN272201100021I
Set-asideNot reported
Pricing typeCOST PLUS FIXED FEE
Obligations$7.2M
Current contract value$7.2M
Potential contract value / ceiling$9.5M
Start dateSep 17, 2015
Current end dateJan 31, 2024
Potential end dateJan 31, 2024
Latest award activityAug 27, 2026
Source loadedSep 19, 2026

Funding and modification history

Showing the latest 10 of 10 loaded transactions. Negative values are deobligations.

DateModificationObligation changeDescription
Aug 27, 2026P00009$-712.3KNIAID PRECLINICAL DEVELOPMENT SUPPORT - PRODUCTION OF ECD4-IG PROTEIN
Nov 17, 2022P00008$0NIAID PRECLINICAL DEVELOPMENT SUPPORT - PRODUCTION OF ECD4-IG PROTEIN
Jun 2, 2021P00007$0NIAID PRECLINICAL DEVELOPMENT SUPPORT - PRODUCTION OF ECD4-IG PROTEIN
Oct 27, 2020P00006$955.9KNIAID PRECLINICAL DEVELOPMENT SUPPORT - PRODUCTION OF ECD4-IG PROTEIN
Sep 29, 2020P00005$-0NIAID PRECLINICAL DEVELOPMENT SUPPORT - PRODUCTION OF ECD4-IG PROTEIN
Sep 24, 2020P00004$-33.6KNIAID PRECLINICAL DEVELOPMENT SUPPORT - PRODUCTION OF ECD4-IG PROTEIN
Sep 16, 2019P00003$198.9KNIAID PRECLINICAL DEVELOPMENT SUPPORT - PRODUCTION OF ECD4-IG PROTEIN
Apr 30, 20182$0IGF::OT::IGF NIAID PRECLINICAL DEVELOPMENT SUPPORT - PRODUCTION OF ECD4-IG PROTEIN
Aug 16, 20161$374.1KIGF::OT::IGF NIAID PRECLINICAL DEVELOPMENT SUPPORT - PRODUCTION OF ECD4-IG PROTEIN
Sep 17, 20150$6.4MIGF::OT::IGF NIAID PRECLINICAL DEVELOPMENT SUPPORT - PRODUCTION OF ECD-IG PROTEIN

Research next steps

  1. Confirm the ordering vehicle and your eligibility or a qualified teaming route.
  2. Review the award scope and buyer evidence before making a bid/no-bid decision.